{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:18:03Z","timestamp":1783099083902,"version":"3.54.6"},"reference-count":87,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011684","name":"Crohn's and Colitis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.gtc.2025.08.003","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:25:01Z","timestamp":1761654301000},"page":"107-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Biomarkers for Disease Activity in Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"55","author":[{"given":"Jalpa","family":"Devi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Syal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parakkal","family":"Deepak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gtc.2025.08.003_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.gastro.2020.03.039","article-title":"Deep remission at 1 year prevents progression of early Crohn\u2019s disease","volume":"159","author":"Ungaro","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.003_bib2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.14309\/ajg.0000000000002122","article-title":"Prevalence and correlations of gastrointestinal symptoms with endoscopic and histologic mucosal healing in Crohn\u2019s disease","volume":"118","author":"Tse","year":"2023","journal-title":"Official journal of the American College of Gastroenterology| ACG"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.003_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.gie.2018.09.025","article-title":"Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn\u2019s disease","volume":"89","author":"Carman","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gtc.2025.08.003_bib4","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1007\/s10620-020-06568-w","article-title":"Understanding determinants of patient preferences between stool tests and colonoscopy for the assessment of disease activity in inflammatory bowel disease","volume":"66","author":"Barsky","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.003_bib5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/j.gastro.2023.09.029","article-title":"AGA clinical practice guideline on the role of biomarkers for the management of Crohn\u2019s disease","volume":"165","author":"Ananthakrishnan","year":"2023","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.003_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","article-title":"AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis","volume":"164","author":"Singh","year":"2023","journal-title":"Gastroenterology"},{"issue":"10114","key":"10.1016\/j.gtc.2025.08.003_bib7","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn\u2019s disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.003_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-021-00555-w","article-title":"Precision medicine in IBD: genes, drugs, bugs and omics","volume":"19","author":"Mao","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.gtc.2025.08.003_bib9","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Investig"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.003_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2362.1982.tb02244.x","article-title":"Serum levels of C-reactive protein in Crohn\u2019s disease and ulcerative colitis","volume":"12","author":"Fagan","year":"1982","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"10.1016\/j.gtc.2025.08.003_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.MIB.0000173271.18319.53","article-title":"Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease","volume":"11","author":"Solem","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.gtc.2025.08.003_bib12","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/ibd\/izy100","article-title":"Genetic variation affects C-reactive protein elevations in Crohn\u2019s disease","volume":"24","author":"Moran","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.gtc.2025.08.003_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2036.2006.03093.x","article-title":"The+ 1059G\/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn\u2019s disease","volume":"24","author":"Thalmaier","year":"2006","journal-title":"Aliment Pharmacol Therapeut"},{"issue":"11","key":"10.1016\/j.gtc.2025.08.003_bib14","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.cgh.2008.06.010","article-title":"Relationships between disease activity and serum and fecal biomarkers in patients with Crohn\u2019s disease","volume":"6","author":"Jones","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"18","key":"10.1016\/j.gtc.2025.08.003_bib15","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i18.104206","article-title":"Role of serological biomarkers in evaluating and predicting endoscopic activity in inflammatory bowel disease","volume":"31","author":"Liu","year":"2025","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gtc.2025.08.003_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.gastrohep.2016.01.015","article-title":"Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease","volume":"39","author":"Miranda-Garcia","year":"2016","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.003_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ecco-jcc\/jjw132","article-title":"Leucine-rich alpha-2 glycoprotein is a serum biomarker of mucosal healing in ulcerative colitis","volume":"11","author":"Shinzaki","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gtc.2025.08.003_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000002952","article-title":"The usefulness of serum leucine-rich alpha-2 glycoprotein as a novel biomarker in monitoring inflammatory bowel disease: a systematic review and meta-analysis","author":"Ojaghi Shirmard","year":"2025","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.003_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00535-021-01793-0","article-title":"Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study","volume":"56","author":"Shinzaki","year":"2021","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.003_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/j.gastro.2019.10.034","article-title":"Development and validation of a test to monitor endoscopic activity in patients with Crohn\u2019s disease based on serum levels of proteins","volume":"158","author":"D\u2019Haens","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.003_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3892\/br.2016.751","article-title":"Calprotectin as a diagnostic tool for inflammatory bowel diseases","volume":"5","author":"Chatzikonstantinou","year":"2016","journal-title":"Biomed Rep"},{"key":"10.1016\/j.gtc.2025.08.003_bib22","first-page":"21","article-title":"Fecal calprotectin in inflammatory bowel disease","author":"Walsham","year":"2016","journal-title":"Clin Exp Gastroenterol"},{"issue":"11\u201312","key":"10.1016\/j.gtc.2025.08.003_bib23","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/apt.17754","article-title":"Systematic review with meta-analysis: diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults","volume":"58","author":"Dajti","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.003_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.15403\/jgld.2014.1121.273.pti","article-title":"Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis","volume":"27","author":"Rokkas","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.gtc.2025.08.003_bib25","article-title":"Fecal calprotectin correlates with disease extent but remains a reliable marker of mucosal healing in ulcerative colitis","volume":"10","author":"Steinsb\u00f8","year":"2022","journal-title":"Official journal of the American College of Gastroenterology| ACG"},{"issue":"7","key":"10.1016\/j.gtc.2025.08.003_bib26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/00365521.2015.1008035","article-title":"Impact of disease location on fecal calprotectin levels in Crohn\u2019s disease","volume":"50","author":"Gecse","year":"2015","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10.1016\/j.gtc.2025.08.003_bib27","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/ibd\/izaa269","article-title":"Fecal calprotectin is highly effective to detect endoscopic ulcerations in Crohn\u2019s disease regardless of disease location","volume":"27","author":"Buisson","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"16","key":"10.1016\/j.gtc.2025.08.003_bib28","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3748\/wjg.v27.i16.1828","article-title":"Surrogate markers of mucosal healing in inflammatory bowel disease: a systematic review","volume":"27","author":"State","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2025.08.003_bib29","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000174","article-title":"Fecal calprotectin predicts mucosal healing in patients with ulcerative colitis treated with biological therapies: a prospective study","volume":"11","author":"Bertani","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.003_bib30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cgh.2022.07.027","article-title":"Prognostic value of fecal calprotectin to inform treat-to-target monitoring in ulcerative colitis","volume":"21","author":"Dulai","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"33","key":"10.1016\/j.gtc.2025.08.003_bib31","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.3748\/wjg.v24.i33.3681","article-title":"From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting","volume":"24","author":"Mumolo","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.003_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1139\/o11-056","article-title":"Lactoferrin, a key molecule in immune and inflammatory processes","volume":"90","author":"Legrand","year":"2012","journal-title":"Biochem Cell Biol"},{"issue":"8","key":"10.1016\/j.gtc.2025.08.003_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejim.2015.06.015","article-title":"The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn\u2019s disease activity","volume":"26","author":"Klimczak","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.003_bib34","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.003_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCG.0000000000001212","article-title":"Fecal lactoferrin for assessment of inflammatory bowel disease activity: a systematic review and meta-analysis","volume":"54","author":"Dai","year":"2020","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.gtc.2025.08.003_bib36","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1111\/j.1572-0241.2005.00231.x","article-title":"Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test","volume":"100","author":"Vilkin","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.gtc.2025.08.003_bib37","first-page":"553","article-title":"Fecal immunochemical test for hemoglobin versus fecal calprotectin to monitor endoscopic activity in inflammatory bowel disease","volume":"115","author":"Latorre A\u00f1\u00f3","year":"2023","journal-title":"Rev Esp Enferm Dig"},{"issue":"5","key":"10.1016\/j.gtc.2025.08.003_bib38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/MIB.0000000000000728","article-title":"Fecal immunochemical test versus fecal calprotectin for prediction of mucosal healing in Crohn\u2019s disease","volume":"22","author":"Inokuchi","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2025.08.003_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/bjr\/tqaf120","article-title":"Quantified motility in Crohn\u2019s disease to evaluate stricture composition using cine-MRI","author":"Beek","year":"2025","journal-title":"Br J Radiol"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.003_bib40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S2468-1253(18)30054-2","article-title":"Diffusion-weighted MRI in inflammatory bowel disease","volume":"3","author":"Pouillon","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.003_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0284185120931689","article-title":"Intravoxel incoherent motion MRI in evaluating inflammatory activity in ulcerative colitis: a pilot study","volume":"62","author":"Podg\u00f3rska","year":"2021","journal-title":"Acta Radiol"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2025.08.003_bib42","article-title":"CTE-based radiomics models can identify mucosal healing in patients with Crohn\u2019s disease","volume":"30","author":"Rong","year":"2023","journal-title":"Acad Radiol"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.003_bib43","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i3.102283","article-title":"Computed tomography enterography-based radiomics for assessing mucosal healing in patients with small bowel Crohn\u2019s disease","volume":"31","author":"Ding","year":"2025","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gtc.2025.08.003_bib44","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/ibd.21551","article-title":"Magnetic resonance imaging for evaluation of Crohn\u2019s disease: validation of parameters of severity and quantitative index of activity","volume":"17","author":"Rimola","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.gtc.2025.08.003_bib45","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.dld.2017.08.033","article-title":"Magnetic resonance index of activity (MaRIA) and Clermont score are highly and equally effective MRI indices in detecting mucosal healing in Crohn\u2019s disease","volume":"49","author":"Buisson","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.003_bib46","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.gastro.2019.03.051","article-title":"Development and validation of a simplified magnetic resonance index of activity for Crohn\u2019s disease","volume":"157","author":"Ordas","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.003_bib47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2019.08.061","article-title":"The simplified magnetic resonance index of activity (MARIA) for Crohn\u2019s disease is strongly correlated with the MARIA and Clermont score: an external validation","volume":"158","author":"Williet","year":"2020","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.gtc.2025.08.003_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210159","article-title":"Systematic review: urine biomarker discovery for inflammatory bowel disease diagnosis","volume":"24","author":"Baldan-Martin","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.003_bib49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ecco-jcc\/jjaa216","article-title":"Expert consensus on optimal acquisition and development of the international bowel ultrasound segmental activity score [IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn\u2019s disease","volume":"15","author":"Novak","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.003_bib50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cgh.2016.10.040","article-title":"Use of intestinal ultrasound to monitor Crohn\u2019s disease activity","volume":"15","author":"Kucharzik","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.003_bib51","doi-asserted-by":"crossref","DOI":"10.4253\/wjge.v17.i3.97016","article-title":"Non-invasive monitoring of inflammatory bowel disease using intestinal ultrasound","volume":"17","author":"Abid","year":"2025","journal-title":"World J Gastrointest Endosc"},{"key":"10.1016\/j.gtc.2025.08.003_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/ueg2.70053","article-title":"IBUS-SAS is a highly accurate intestinal ultrasound score for predicting endoscopic disease activity in ulcerative colitis","author":"Fischer","year":"2025","journal-title":"United European Gastroenterol J"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.003_bib53","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1053\/j.gastro.2022.08.038","article-title":"Intestinal ultrasound is accurate to determine endoscopic response and remission in patients with moderate to severe ulcerative colitis: a longitudinal prospective cohort study","volume":"163","author":"de Voogd","year":"2022","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.gtc.2025.08.003_bib54","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/ibd\/izab216","article-title":"Intestinal ultrasound to evaluate treatment response during pregnancy in patients with inflammatory bowel disease","volume":"28","author":"De Voogd","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.gtc.2025.08.003_bib55","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/ibd\/izy091","article-title":"Real-time interobserver agreement in bowel ultrasonography for diagnostic assessment in patients with Crohn\u2019s disease: an international multicenter study","volume":"24","author":"Calabrese","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.gtc.2025.08.003_bib56","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/ibd\/izaa062","article-title":"Novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-TNF: neutrophil-to-lymphocyte Ratio and platelet-to-lymphocyte Ratio","volume":"26","author":"Bertani","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.003_bib57","article-title":"Elevated pretreatment plasma oncostatin M is associated with poor biochemical response to infliximab","volume":"1","author":"Minar","year":"2019","journal-title":"Crohns Colitis 360"},{"issue":"11","key":"10.1016\/j.gtc.2025.08.003_bib58","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1097\/MIB.0000000000000547","article-title":"Assessment of circulating MicroRNAs for the diagnosis and disease activity evaluation in patients with ulcerative colitis by using the nanostring technology","volume":"21","author":"Polytarchou","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.003_bib59","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.15159","article-title":"Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease","volume":"49","author":"Chen","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.gtc.2025.08.003_bib60","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2025.08.003_bib61","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2015.01.026","article-title":"Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn\u2019s disease after surgery","volume":"148","author":"Wright","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.003_bib62","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/ajg.2015.30","article-title":"Levels of fecal calprotectin are associated with the severity of postoperative endoscopic recurrence in asymptomatic patients with Crohn\u2019s disease","volume":"110","author":"Boschetti","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.003_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2023.10.015","article-title":"AGA clinical practice guideline on the management of pouchitis and inflammatory pouch disorders","volume":"166","author":"Barnes","year":"2024","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.gtc.2025.08.003_bib64","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.cgh.2021.11.012","article-title":"Fecal calprotectin is increased in pouchitis and progressively increases with more severe endoscopic and histologic disease","volume":"20","author":"Ollech","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.gtc.2025.08.003_bib65","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/MEG.0000000000002638","article-title":"Sensitivity and specificity of diagnostic modalities in pouchitis: a systematic review and meta-analysis","volume":"35","author":"Nieto","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.003_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ecco-jcc\/jjab125","article-title":"Accuracy of gastrointestinal ultrasound and calprotectin in the assessment of inflammation and its location in patients with an ileoanal pouch","volume":"16","author":"Ardalan","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.003_bib67","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/imj.16648","article-title":"Stomal calprotectin as a biomarker for assessing Crohn disease activity in patients with stomas","volume":"55","author":"Abeyratne","year":"2025","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.gtc.2025.08.003_bib68","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12876-025-03652-1","article-title":"Fecal calprotectin from ileostomy output in patients with Crohn\u2019s disease","volume":"25","author":"Park","year":"2025","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.003_bib69","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.003_bib70","doi-asserted-by":"crossref","DOI":"10.1111\/codi.70026","article-title":"Faecal calprotectin as a non-invasive marker of Crohn\u2019s disease in anal fistulas","volume":"27","author":"Perregaard","year":"2025","journal-title":"Colorectal Dis"},{"issue":"3","key":"10.1016\/j.gtc.2025.08.003_bib71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ueg2.12622","article-title":"Clinical relevance of calprotectin in patients with perianal fistulas in Crohn\u2019s disease and cryptoglandular fistulas","volume":"13","author":"Becker","year":"2025","journal-title":"United European Gastroenterology Journal"},{"issue":"8","key":"10.1016\/j.gtc.2025.08.003_bib72","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCG.0000000000001244","article-title":"Noninvasive methods for assessing inflammatory bowel disease activity in pregnancy: a systematic review","volume":"53","author":"Tandon","year":"2019","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.003_bib73","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/ibd\/izx055","article-title":"Fecal calprotectin during pregnancy in women with moderate-severe inflammatory bowel disease","volume":"24","author":"Kammerlander","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2025.08.003_bib74","first-page":"341","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis","author":"Van Rheenen","year":"2010","journal-title":"Bmj"},{"issue":"10s","key":"10.1016\/j.gtc.2025.08.003_bib75","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14309\/ajg.0000000000001963","article-title":"Inflammatory bowel disease and pregnancy","volume":"117","author":"Shmidt","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gtc.2025.08.003_bib76","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1053\/j.gastro.2024.06.014","article-title":"AGA clinical practice update on pregnancy-related gastrointestinal and liver disease: expert review","volume":"167","author":"Kothari","year":"2024","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.gtc.2025.08.003_bib77","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.cgh.2024.04.039","article-title":"AGA clinical practice update on the role of intestinal ultrasound in inflammatory bowel disease: commentary","volume":"22","author":"Chavannes","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2025.08.003_bib78","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1097\/AOG.0000000000002355","article-title":"Committee opinion No. 723: guidelines for diagnostic imaging during pregnancy and lactation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.gtc.2025.08.003_bib79","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/ibd\/izaa218","article-title":"Clinical-stage approaches for imaging chronic inflammation and fibrosis in Crohn\u2019s disease","volume":"26","author":"Greer","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.gtc.2025.08.003_bib80","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1136\/gutjnl-2021-326562","article-title":"Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease","volume":"71","author":"Rimola","year":"2022","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.gtc.2025.08.003_bib81","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/ibd\/izaa191","article-title":"A sweat-based wearable enabling technology for real-time monitoring of IL-1\u03b2 and CRP as potential markers for inflammatory bowel disease","volume":"26","author":"Jagannath","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.gtc.2025.08.003_bib82","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1373\/clinchem.2011.177980","article-title":"Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study","volume":"58","author":"Kok","year":"2012","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.gtc.2025.08.003_bib83","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/MIB.0000000000000619","article-title":"Fecal calprotectin measured by patients at home using smartphones\u2014a new clinical tool in monitoring patients with inflammatory bowel disease","volume":"22","author":"Vinding","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.gtc.2025.08.003_bib84","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3748\/wjg.v28.i12.1220","article-title":"Emerging role of colorectal mucus in gastroenterology diagnostics","volume":"28","author":"Nooredinvand","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gtc.2025.08.003_bib85","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/gutjnl-2019-320065","article-title":"Big data in IBD: big progress for clinical practice","volume":"69","author":"Seyed Tabib","year":"2020","journal-title":"Gut"},{"issue":"17","key":"10.1016\/j.gtc.2025.08.003_bib86","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3748\/wjg.v27.i17.1920","article-title":"Artificial intelligence applications in inflammatory bowel disease: emerging technologies and future directions","volume":"27","author":"Gubatan","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2025.08.003_bib87","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2025.03.005","article-title":"Artificial intelligence-driven personalized medicine: transforming clinical practice in inflammatory bowel disease","author":"Iacucci","year":"2025","journal-title":"Gastroenterology"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855325000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855325000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:10:52Z","timestamp":1769184652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855325000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0889855325000548"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2025.08.003","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for Disease Activity in Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2025.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}